ALDH1A1 and prostate carcinoma: ALDH1 activity has been proven to be indicative of radioresistance in CSCs of prostate cancer as it promoted an enhanced DNA repair capacity and gain of the epithelial-to-mesenchymal transition (EMT) features [25].